HBV
- 2
•1982 -first
vaccine made available for use
•purified
suspension of inactivated HBV surface antigens
•antigen obtained
from chronic HBsAg carriers
•Now -vaccine
made from recombinant HBV antigen
•Indications for
vaccination against HBV:
•Žhealth care
professionals
•Žthose at
increased risk for exposure to HBV
•Žindividuals
who have been exposed to body fluids of patient who has tested positive for HBV
•Žif mother
tests positive for HBsAg at delivery, the newborn is treated same as post-exposure
patient